Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Beroni Group's Gross Margin % or its related term are showing as below:
FRA:6B9's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 48.54 * Ranked among companies with meaningful Gross Margin % only.
Beroni Group had a gross margin of 84.11% for the quarter that ended in Jun. 2024 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Beroni Group was 0.00% per year.
Beroni Group (FRA:6B9) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Beroni Group had a gross margin of 84.11% for the quarter that ended in Jun. 2024 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Beroni Group Gross Margin % Related Terms
Beroni Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for Beroni Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:6B9 vs PNXP, CRYM, GCAN: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Beroni Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beroni Group Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beroni Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Beroni Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Beroni Group (FRA:6B9) has a Gross Margin % of 84.11% as of Jun. 2024. Gross margin is the ratio of total gross profit to net sales. View historical data on Beroni Group and its competitors.
Is Beroni Group's Gross Margin % too high?
Beroni Group's current Gross Margin % is 84.11%. The Drug Manufacturers industry median Gross Margin % is 48.54. Beroni Group's value of 84.11% is 73.3% above this industry median. Overall, Beroni Group has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Beroni Group's Gross Margin % compare to PNXP and CRYM?
Beroni Group's Gross Margin % of 84.11% can be compared against companies in the Drug Manufacturers industry. The industry median Gross Margin % is 48.54. Beroni Group's value of 84.11% is 73.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 942 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beroni Group's current Gross Margin % of 84.11% is 73.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Beroni Group and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beroni Group's current Gross Margin % is 84.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beroni Group stock overvalued right now?
Beroni Group (FRA:6B9) has a current Gross Margin % of 84.11%. The current Gross Margin % is 84.11% and 73.3% above the Drug Manufacturers industry median of 48.54. Beroni Group's overall GF Score™ is 57/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Beroni Group (FRA:6B9), the current Gross Margin % is 84.11% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beroni Group Ltd is an Australia based company engaged in the sales of smoking control product (NicoBloc), air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics and viral diagnostic kits and also investing in the research and development of oncology drugs and therapies. It has organized its business into four core business areas: cell therapies, developing new anticancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and detection & diagnosis of infectious diseases. Geographically, the company operates in China.
57GF Score
Get the complete analysis for FRA:6B9
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:6B9 has been successfully added to your 
